FREE SHIPPING ON ORDERS OVER $150

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted DIHEXA | Peptide Synthetic |

$29.36

Quantity
- +
Description

Learn More Diabetes Management Ask about our physician-led diabetes and metabolic optimization program

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often-quoted DIHEXA | Peptide Synthetic |

Not for human consumption, therapeutic use, or diagnostic purposes

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often-quoted DIHEXA | Peptide Synthetic |

All are supplied as lyophilised powder at 99%+ HPLC purity for in-vitro research use only, dispatched Australia-wide with full COA documentation

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often-quoted DIHEXA | Peptide Synthetic |

and they take just seconds to administer

pnb0408 dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often-quoted DIHEXA | Peptide Synthetic |

You may also like

Miduty

US$ 20.40

4.9 (8 reviews)

recommand products